Major Advance in France for R5

R5 Pharmaceuticals Ltd, a leading provider of contract pharmaceutical sciences outsourcing services to the global pharmaceutical and biotechnology industries, is pleased to announce that the French Ministry of Research (Ministere de l’Enseignement Superieur et de la Recherche) has approved R5 as a contract research organization (CRO) carrying out innovative R&D activities for French companies at R5’s laboratories in Nottingham, England. This approval enables companies subject to corporate tax in France to claim tax credits (Crédit d'Impôt sur la Recherche) for work subcontracted to R5.

 

Go back